ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,258 | +3.8% | 176,039 | +3.8% | 0.00% | – |
| Q2 2023 | $232,420 | -23.7% | 169,650 | +31.4% | 0.00% | – |
| Q1 2023 | $304,796 | +101838.5% | 129,151 | 0.0% | 0.00% | – |
| Q4 2022 | $299 | -99.9% | 129,151 | -0.2% | 0.00% | – |
| Q3 2022 | $357,000 | +13.7% | 129,465 | +0.5% | 0.00% | – |
| Q2 2022 | $314,000 | -37.1% | 128,786 | +1.6% | 0.00% | – |
| Q1 2022 | $499,000 | -10.6% | 126,710 | 0.0% | 0.00% | – |
| Q4 2021 | $558,000 | -29.2% | 126,710 | -0.7% | 0.00% | – |
| Q3 2021 | $788,000 | -20.0% | 127,558 | +2.4% | 0.00% | – |
| Q2 2021 | $985,000 | -7.1% | 124,614 | +25.7% | 0.00% | – |
| Q1 2021 | $1,060,000 | – | 99,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |